Open access
2,755
Views
5
CrossRef citations to date
0
Altmetric
Reproductive Medicine
FDA approved vs. Pharmacy compounded 17-OHPC—current issues for obstetricians to consider in reducing recurrent preterm birth
David L. GandellDepartment of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA; Correspondence[email protected]
, Michael D. RandellOBGYN Atlanta, Emory Saint Joseph’s Hospital, Atlanta, GA, USA;
& Jennifer L. GudemanAMAG Pharmaceuticals, Waltham, MA, USA
Pages 1393-1401
|
Received 22 Apr 2020, Accepted 07 Jun 2020, Published online: 30 Jun 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.